Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Next-generation treatments for mental disorders.

Literature DB >> 23052292

Next-generation treatments for mental disorders.

Abstract

There has been a steady retreat by the private sector away from developing medications for mental disorders. This retreat comes just as research is identifying new molecular targets, new clinical targets, and new uses of current treatments that may serve as the basis for the next generation of treatments for mental disorders.

Entities: Disease

Mesh：

Substances：
Antidepressive Agents

Year: 2012 PMID： 23052292 DOI： 10.1126/scitranslmed.3004873

Source DB: PubMed Journal: Sci Transl Med ISSN： 1946-6234 Impact factor: 17.956

Keyword Cloud
Cited

68 in total

1. Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.

Authors: Deepak K Sarpal; Miklos Argyelan; Delbert G Robinson; Philip R Szeszko; Katherine H Karlsgodt; Majnu John; Noah Weissman; Juan A Gallego; John M Kane; Todd Lencz; Anil K Malhotra
Journal: Am J Psychiatry Date: 2015-08-28 Impact factor: 18.112

10. Heightened extended amygdala metabolism following threat characterizes the early phenotypic risk to develop anxiety-related psychopathology.

Authors: A J Shackman; A S Fox; J A Oler; S E Shelton; T R Oakes; R J Davidson; N H Kalin
Journal: Mol Psychiatry Date: 2016-08-30 Impact factor: 15.992

Next-generation treatments for mental disorders.

1. Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.

2. Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders.

Review 3. The role of machine learning in neuroimaging for drug discovery and development.

4. A Roadmap for the Development of Applied Computational Psychiatry.

5. Evidence of systematic attenuation in the measurement of cognitive deficits in schizophrenia.

Review 6. The Psychiatrist as Clinical Behavioural Scientist.

Review 7. Dispositional negativity: An integrative psychological and neurobiological perspective.

8. Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health.

9. Schizophrenia research in 2013: are we making progress?

10. Heightened extended amygdala metabolism following threat characterizes the early phenotypic risk to develop anxiety-related psychopathology.